Schedule of earnings per share |
A
summary of the net income (loss) and shares used to compute net income (loss) per share for the three and six-month periods ended
March 31, 2018 and 2017 is as follows:
|
Three
Months Ended March 31, |
|
2018 |
|
2017 |
Net loss for computation of basic and diluted
net loss per share: |
|
|
|
Net loss |
$ |
(2,659,600 |
) |
|
$ |
(1,452,000 |
) |
Basic and diluted net loss per share: |
|
|
|
Basic and diluted net loss per share |
$ |
(0.61 |
) |
|
$ |
(0.61 |
) |
Basic and diluted
weighted average shares outstanding |
4,362,564 |
|
|
2,372,394 |
|
|
|
|
|
Anti-dilutive common equivalent shares not included
in the computation of dilutive net loss per share: |
|
|
|
Warrants |
5,617,481 |
|
|
7,032 |
|
Restricted common
stock |
280,250 |
|
|
143,750 |
|
Options |
544,059 |
|
|
334,428 |
|
Total warrants
and options |
6,451,790 |
|
|
485,210 |
|
|
Six
Months Ended March 31, |
|
2018 |
|
2017 |
Net loss for computation of basic and diluted
net loss per share: |
|
|
|
Net loss |
$ |
(5,429,000 |
) |
|
$ |
(2,892,200 |
) |
Basic and diluted net loss per share: |
|
|
|
Basic and diluted net loss per share |
$ |
(1.25 |
) |
|
$ |
(1.29 |
) |
Basic and diluted
weighted average shares outstanding |
4,347,745 |
|
|
2,236,728 |
|
|
|
|
|
Anti-dilutive common equivalent shares not included
in the computation of dilutive net loss per share: |
|
|
|
Warrants |
5,617,481 |
|
|
7,093 |
|
Restricted common
stock |
280,250 |
|
|
143,750 |
|
Options |
554,059 |
|
|
329,766 |
|
Total warrants
and options |
6,451,790 |
|
|
480,609 |
|
|